Bisolvon 2-IN-1 cough syrup for adults

Bisolvon is a globally recognized brand specializing in respiratory health products, particularly known for its mucolytic and antitussive treatments. Originally developed in Germany by Boehringer Ingelheim, the brand gained prominence for the active ingredient bromhexine.

In recent years, the brand underwent a significant ownership change when Sanofi acquired Boehringer Ingelheim's consumer healthcare business in a strategic asset swap. This development placed Bisolvon under the umbrella of one of the world's largest pharmaceutical entities. The manufacturing of specific products like the 2-in-1 syrup shown frequently occurs in specialized European facilities, notably in Italy, to serve the Dutch and European markets.